Longboard Pharmaceuticals, Inc. Shareholders' Equity
Longboard Pharmaceuticals, Inc. had Shareholders' Equity of $275.19 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-11-07
- 2024-09-30: Stockholders' Equity Attributable to Parent $275.19M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $294.60M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $313.71M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $40.92M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-09-30 | $275.19M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $294.60M 10-Q · filed 2024-11-07 |
| 2024-03-31 | $313.71M 10-Q · filed 2024-11-07 |
| 2023-12-31 | $40.92M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $52.04M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $58.11M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $72.13M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $61.47M 10-Q · filed 2024-11-07 |
| 2022-09-30 | $72.04M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $82.97M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $93.86M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $103.32M 10-K · filed 2024-03-12 |
| 2021-09-30 | $111.65M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $117.45M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $119.59M 10-Q · filed 2022-11-03 |
| 2020-12-31 | -$2.69M 10-K · filed 2023-03-02 |
| 2020-09-30 | -$943.00K 10-Q · filed 2021-11-04 |
| 2020-06-30 | $185.00K 10-Q · filed 2021-11-04 |
| 2020-03-31 | -$40.00K 10-Q · filed 2021-11-04 |
| 2020-01-03 | $0.00 10-K · filed 2022-03-03 |